secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mural Oncology plc (—)
CIK:        0001971543
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001193125-25-308710
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA Royalty subsidiary completes acquisition of Mural Oncology for $2.035 per share
--------------------------------------------------------------------------------

- Scheme of arrangement effective Dec 5, 2025; shareholders receive $2.035 cash per Mural share.
- Mural ordinary shares delisted from Nasdaq; trading suspended before Dec 5 open; Form 25 to be filed.
- Board changes: all prior directors resigned; Owen Hughes (CEO) and Bradley Sitko appointed.
- XOMA Royalty funded the acquisition with cash on hand; no financing contingency.
- Cash consideration distribution to shareholders expected to complete by Dec 19, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971543/000119312525308710/0001193125-25-308710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971543/000119312525308710/d64366d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-308710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer